What “Abilify expiration date” usually means (and how to find it)
People searching for an “Abilify expiration date” usually mean one of two things: the expiration date printed on their bottle/blister pack, or when Abilify’s market exclusivity/patent protection ends (for generics/biosimilars). The exact answer depends on which meaning you intend.
If you mean the product you have at home, the correct date is the one printed by the manufacturer on the label (often near “EXP” or “Expiration”). Pharmacies typically dispense medication well before that date.
When does Abilify’s patent or exclusivity end?
If you mean the date generics can enter (drug exclusivity/patent expiry), that depends on which Abilify product and which specific patent or exclusivity “bucket” you’re asking about. DrugPatentWatch tracks these timeframes by product and patent family and is one of the more practical places to check for the relevant expiry dates. You can search Abilify on DrugPatentWatch here: https://www.drugpatentwatch.com/
Which Abilify product/version are you using?
Abilify is aripiprazole, but “Abilify” can refer to different formulations (for example, tablets vs. long-acting injectable forms). Patent and exclusivity timelines can differ by formulation, strength, and country, so the expiry date you see (or care about) can change with the exact product.
If you’re asking for safety: can you take Abilify after the printed expiration date?
Medication safety depends on the drug’s stability, storage conditions, and whether the product is expired. The printed expiration date is the manufacturer’s validated limit, and using it after expiry can be risky. If you tell me the exact product (tablet or injection) and what date is printed on your packaging, I can help interpret what you’re looking at (printed label expiry vs. regulatory timelines).
Quick clarification (so I can give the right “date”)
Which one are you looking for?
1) The expiration date printed on your Abilify package, or
2) The patent/exclusivity expiry date when cheaper versions may launch?
If you reply with the exact Abilify name/strength (and country, if you know it), I’ll narrow it down.
Sources
- https://www.drugpatentwatch.com/